Compare NXP & TALK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NXP | TALK |
|---|---|---|
| Founded | 1992 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medical/Nursing Services |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 728.1M | 656.0M |
| IPO Year | N/A | N/A |
| Metric | NXP | TALK |
|---|---|---|
| Price | $14.51 | $3.77 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $4.88 |
| AVG Volume (30 Days) | 70.0K | ★ 1.3M |
| Earning Date | 01-01-0001 | 02-19-2026 |
| Dividend Yield | ★ 4.04% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.54 | 0.03 |
| Revenue | N/A | ★ $214,593,000.00 |
| Revenue This Year | N/A | $23.86 |
| Revenue Next Year | N/A | $22.25 |
| P/E Ratio | ★ $26.81 | $149.22 |
| Revenue Growth | N/A | ★ 18.37 |
| 52 Week Low | $12.91 | $2.22 |
| 52 Week High | $14.89 | $4.36 |
| Indicator | NXP | TALK |
|---|---|---|
| Relative Strength Index (RSI) | 76.40 | 45.91 |
| Support Level | $13.89 | $3.68 |
| Resistance Level | $14.19 | $3.99 |
| Average True Range (ATR) | 0.09 | 0.20 |
| MACD | 0.05 | -0.04 |
| Stochastic Oscillator | 100.00 | 16.03 |
Nuveen Select Tax Free Income Portfolio is a closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax, consistent with preservation of capital. The fund invests a majority of its assets in municipal securities and other related investments, the income from which is exempt from regular federal income tax and federal alternative minimum tax.
Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.